OBJECTIVE: To analyze the characteristics of patients with lung cancer. METHODS: A retrospective descriptive study of patients receiving a histopathological diagnosis of lung cancer between 1995 and 2002 in the city of Manaus, Brazil. Data were collected from the medical archives of three hospitals. Statistical analyses were carried out, and survival curves were generated by means of an actuarial estimator. RESULTS: Of the 352 patients selected, 262 (74.4%) were male and 90 (25.6%) were female. The mean age was 62 years. The following histological types were identified: squamous cell carcinoma, 62.8%; adenocarcinoma, 24.7%; small cell carcinoma, 9.1%; and large cell carcinoma, 3.4%. The most common stages were stages IIIB and IV, in 45% and 21.5%, respectively. Of the total sample, 73.4% were submitted to treatment. Of these, 51.4% underwent radiotherapy; 16.6%, surgery; 15.8%, chemotherapy; and 16.2%, radiotherapy in association with chemotherapy. Cumulative survival rates were low: three-year survival was 6.5%, and five-year survival was 3.5%. CONCLUSIONS: In this group of patients with lung cancer, survival rates were considerably lower than those reported in the literature. This might be attributable to the limited access to the specialized health care system and the advanced stage of the disease at diagnosis.
OBJECTIVE: To analyze the characteristics of patients with lung cancer. METHODS: A retrospective descriptive study of patients receiving a histopathological diagnosis of lung cancer between 1995 and 2002 in the city of Manaus, Brazil. Data were collected from the medical archives of three hospitals. Statistical analyses were carried out, and survival curves were generated by means of an actuarial estimator. RESULTS: Of the 352 patients selected, 262 (74.4%) were male and 90 (25.6%) were female. The mean age was 62 years. The following histological types were identified: squamous cell carcinoma, 62.8%; adenocarcinoma, 24.7%; small cell carcinoma, 9.1%; and large cell carcinoma, 3.4%. The most common stages were stages IIIB and IV, in 45% and 21.5%, respectively. Of the total sample, 73.4% were submitted to treatment. Of these, 51.4% underwent radiotherapy; 16.6%, surgery; 15.8%, chemotherapy; and 16.2%, radiotherapy in association with chemotherapy. Cumulative survival rates were low: three-year survival was 6.5%, and five-year survival was 3.5%. CONCLUSIONS: In this group of patients with lung cancer, survival rates were considerably lower than those reported in the literature. This might be attributable to the limited access to the specialized health care system and the advanced stage of the disease at diagnosis.
Authors: Luiz Henrique Araujo; Clarissa Baldotto; Gilberto de Castro; Artur Katz; Carlos Gil Ferreira; Clarissa Mathias; Eldsamira Mascarenhas; Gilberto de Lima Lopes; Heloisa Carvalho; Jaques Tabacof; Jeovany Martínez-Mesa; Luciano de Souza Viana; Marcelo de Souza Cruz; Mauro Zukin; Pedro De Marchi; Ricardo Mingarini Terra; Ronaldo Albuquerque Ribeiro; Vladmir Cláudio Cordeiro de Lima; Gustavo Werutsky; Carlos Henrique Barrios Journal: J Bras Pneumol Date: 2018 Jan-Feb Impact factor: 2.624
Authors: Marcelo Bragança Dos Reis Oliveira; Larissa Costa Souza; Ermides Javier Garcia Sampayo; Gustavo Sobral de Carvalho; Fernanda Carvalho de Queiroz Mello; Marcos Eduardo Machado Paschoal Journal: Rev Bras Ortop (Sao Paulo) Date: 2019-09-19
Authors: Mariana Schettini Soares; Laura Maria Coltro; Pedro Henrique Cunha Leite; Priscila Berenice Costa; Letícia Leone Lauricella; Paulo Manuel Pêgo-Fernandes; Ricardo Mingarini Terra Journal: J Bras Pneumol Date: 2020-12-16 Impact factor: 2.624